Log In Sign up
The largest database of trusted experimental protocols

Pamp 9 20

Manufactured by GenScript
Visit Supplier

PAMP (9-20) is a synthetic peptide that corresponds to the 9-20 amino acid sequence of the Pathogen-Associated Molecular Pattern (PAMP) domain. It is used in research applications to study immune response pathways.

Automatically generated - may contain errors

Lab products found in correlation

Ofloxacin, by Merck Group (2 mentions) Tubocurarine, by Merck Group (2 mentions) Vespid mastoparan, by Merck Group (2 mentions) Rocuronium, by Merck Group (2 mentions) Kallidin, by AnaSpec (2 mentions) Mastoparan, by AnaSpec (2 mentions) Cetrorelix, by AnaSpec (2 mentions) Octreotide, by AnaSpec (2 mentions) Sermorelin, by AnaSpec (2 mentions) Mivacurium, by Santa Cruz Biotechnology (2 mentions) Levofloxacin, by Merck Group (2 mentions) Moxifloxacin, by Merck Group (2 mentions) Substance p, by AnaSpec (2 mentions) Compound 48 80, by Merck Group (2 mentions) Recombinant human insulin, by Roche (2 mentions) Cortistatin, by Bio-Techne (2 mentions) Leuprolide, by GenScript (2 mentions) Icatibant hoe 140, by AnaSpec (2 mentions) Atracurium, by Santa Cruz Biotechnology (2 mentions) Goat anti mouse ige ab9162, by Abcam (2 mentions)

2 protocols using pamp 9 20

1

Evaluation of Biologically Active Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound 48/80, vespid mastoparan, rocuronium, tubocurarine, ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin were from Sigma. Cortistatin was from Tocris Biosciences. PAMP (9-20) was custom synthesized and purified to ≥98% by Genscript. Leuprolide was from Genscript. Substance P, kallidin, mastoparan, cetrorelix, octreotide, sermorelin (growth hormone releasing factor 1-29), icatibant (HOE-140) were from Anaspec. Atracurium and mivacurium were from Santa Cruz Biotechnology. Recombinant human insulin was from Roche. Goat anti-mouse IgE (Ab9162) was from Abcam.
McNeil B.D., Pundir P., Meeker S., Han L., Undem B.J., Kulka M, & Dong X. (2014). Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions. Nature, 519(7542), 237-241.
+ Open protocol
+ Expand
2

Evaluation of Biologically Active Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Compound 48/80, vespid mastoparan, rocuronium, tubocurarine, ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin were from Sigma. Cortistatin was from Tocris Biosciences. PAMP (9-20) was custom synthesized and purified to ≥98% by Genscript. Leuprolide was from Genscript. Substance P, kallidin, mastoparan, cetrorelix, octreotide, sermorelin (growth hormone releasing factor 1-29), icatibant (HOE-140) were from Anaspec. Atracurium and mivacurium were from Santa Cruz Biotechnology. Recombinant human insulin was from Roche. Goat anti-mouse IgE (Ab9162) was from Abcam.
McNeil B.D., Pundir P., Meeker S., Han L., Undem B.J., Kulka M, & Dong X. (2014). Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions. Nature, 519(7542), 237-241.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!